Sila Realty Trust (SILA) Q4 2024 earnings summary

Executive summary

• Achieved a strong Q4 2024 and full-year net income of $42.7 million ($0.75 per diluted share), up from $24 million ($0.42 per share) in 2023, with prudent investing, proactive portfolio management, and over 1 million sq.ft. of lease renewals, including a major extension with Post Acute Medical.

• Listed on the NYSE in June 2024, outperforming the S&P and RMZ on a total return basis, and completed a $50 million Dutch Auction tender offer, increasing market visibility and institutional shareholder diversification.

• Portfolio expanded to 135 properties (5.3M sq ft), with 96% leased and a 9.7-year weighted average lease term.

• Executed $164 million in accretive investments, including eight assets and two mezzanine loans for healthcare facility development, with purchase options upon completion.

• Resolved all GenesisCare bankruptcy exposure and are actively marketing the only Steward bankruptcy property for sale or lease.

Financial highlights

• GAAP net income for 2024 was $42.7 million ($0.75 per diluted share), up from $24 million ($0.42 per share) in 2023.

• Q4 2024 cash NOI was $41 million, down 4.3% year-over-year; full-year 2024 cash NOI was $168.6 million, down 3.6% from 2023.

• AFFO for Q4 2024 was $30.2 million ($0.54 per share), and for the year $131.1 million ($2.31 per share), nearly flat year-over-year.

• Q4 FFO was $28.6 million ($0.51 per share); full year FFO was $118.2 million ($2.08 per share).

• Dividend payout to AFFO ratio was 73.3% for Q4; annualized distribution per share was $1.60.

Outlook and guidance

• Targeting 7.5%-15% annual enterprise value growth in 2025, with a focus on disciplined, accretive acquisitions and a simple, transparent business model.

• Management expects continued growth in 2025, supported by a new $600 million revolving credit facility and a robust acquisition pipeline.

• Majority of 2025 transaction volume expected to be acquisitions, with some mezzanine loan activity; cap rate range for new investments is 6.5%-7.5%.

• Mezzanine loans to be fully funded by Q2 2025, with interest income recognized as funds are deployed; construction completion expected in H1 2026.

• Quarterly dividend of $0.40/share declared for Q1 2025.